Rapid Onset and Sustained Efficacy of Onfasprodil (MIJ821), a Novel NR2B Negative Allosteric Modulator, in Patients With Treatment-Resistant Depression: A Phase 2, Randomized, Placebo-Controlled, Proof-of-Concept Study. - Shelton RC; Litman RE; Hassman H; Walling DP; Ros Montalbán S; Salvà-Coll J; Zajecka J; Sverdlov O; Gomez-Mancilla B; Healy MP; Shanker YG; Berkheimer M; et al. (The Journal of clinical psychiatry, 2025)